Article thumbnail

Beta regression model to assess the influence of the study variables on CFA, including the dose of enzymes (TOD) and the individual factors intake of proton pump inhibitors (PPI), age and transit time.

By Joaquim Calvo-Lerma (6393341), Jessie Hulst (6449027), Mieke Boon (6107720), Carla Colombo (5564183), Etna Masip (6449030), Mar Ruperto (6449033), Victoria Fornés-Ferrer (4162279), Els van der Wiel (6449036), Ine Claes (6449039), Maria Garriga (6449042), Maria Roca (4667980), Paula Crespo-Escobar (6449045), Anna Bulfamante (6449048), Sandra Woodcock (6449051), Sandra Martínez-Barona (6449054), Ana Andrés (6393347), Kris de Boeck (6449057) and Carmen Ribes-Koninckx (333629)

Abstract

<p>Beta regression model to assess the influence of the study variables on CFA, including the dose of enzymes (TOD) and the individual factors intake of proton pump inhibitors (PPI), age and transit time.</p

Topics: Biochemistry, Medicine, Cell Biology, Biotechnology, Cancer, Infectious Diseases, Mathematical Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, dose, patient characteristics influence, patient characteristics, PERT, Cystic Fibrosis Background, BMI, Intestinal transit time, Pancreatic Enzyme Replacement Therapy, interventional study, 43 paediatric patients, beta regression models, CF, evidence-based method, TOD, CFA
Year: 2019
DOI identifier: 10.1371/journal.pone.0213216.t003
OAI identifier: oai:figshare.com:article/7833413
Provided by: FigShare
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://figshare.com/articles/... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.